---
layout: post
title: "Yesterday I sat down with Dr. Clifford Hudis at the American Society of Clinical Oncology (ASCO) Ann..."
date: 2025-11-24
categories: linkedin
tags: [linkedin, social-media, automation]
linkedin_url: "https://www.linkedin.com/posts/thomas-kurian-469b6219_yesterday-i-sat-down-with-dr-clifford-hudis-activity-7335348609732792321-UlKu?utm_source=social_share_send&utm_medium=member_desktop_web&rcm=ACoAABWNEOYBdb1mUVFywmMzK0UKcw_6cTpqScY"
author: "Harvad Li"
extract_method: "linkedinscraper-rapidapi"
sync_date: "2025-11-24T10:20:07.264Z"
featured_image: "/images/linkedin/linkedin-1763979606644-19-642d18a2abfc0815dd5f2abac21ff566.jpg"
linkedin_stats:
  likes: 1126
  comments: 38
  shares: 67
---

Yesterday I sat down with Dr. Clifford Hudis at the American Society of Clinical Oncology (ASCO) Annual Meeting to discuss the role of AI in oncology. We talked about our recent announcement of the ASCO Guidelines Assistant - a gen AI agent that gives physicians interactive access to clinical guidelines for diagnosing and treating cancer. This is just one example of AI‚Äôs potential to free up clinicians so they can focus on patient care.

In the future, we think AI will act as a support system for both doctors and patients, delivering trustworthy and up-to-date information throughout the healthcare journey.

Read more about the ASCO Guidelines Assistant:¬†https://lnkd.in/gTcxKRvx


![Post Image](/images/linkedin/linkedin-1763979606644-19-642d18a2abfc0815dd5f2abac21ff566.jpg)


---

**Engagement:** üëç 1126 likes ‚Ä¢ üí¨ 38 comments ‚Ä¢ üîÑ 67 shares

*This post was automatically synced from LinkedIn on 11/24/2025.*

**Original LinkedIn Post:** [View on LinkedIn](https://www.linkedin.com/posts/thomas-kurian-469b6219_yesterday-i-sat-down-with-dr-clifford-hudis-activity-7335348609732792321-UlKu?utm_source=social_share_send&utm_medium=member_desktop_web&rcm=ACoAABWNEOYBdb1mUVFywmMzK0UKcw_6cTpqScY)
